Verition Fund Management LLC - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAD4. A total of 37 filers reported holding BRIDGEBIO PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Verition Fund Management LLC ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$4,281,750
-4.8%
5,709
-21.5%
0.05%
-16.7%
Q2 2023$4,498,617
-34.1%
7,269
-31.1%
0.06%
-36.2%
Q1 2023$6,825,676
+61.8%
10,544
-99.9%
0.09%
+42.4%
Q4 2022$4,218,955
-14.0%
11,048,000
-50.0%
0.07%
+17.9%
Q3 2022$4,906,902
-5.1%
22,096,000
+100.0%
0.06%
-9.7%
Q1 2022$5,170,00011,048,0000.06%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
Diameter Capital Partners LP 52,257,000$39,745,1068.72%
Context Capital Management, LLC 32,083$24,0521.93%
BRAIDWELL LP 67,294,000$50,470,5001.60%
DeepCurrents Investment Group LLC 17,855,000$13,514,0560.59%
Aequim Alternative Investments LP 20,000,000$15,000,0000.57%
ADVENT CAPITAL MANAGEMENT /DE/ 29,488,000$22,116,0000.51%
SILVERBACK ASSET MANAGEMENT LLC 5,000,000$3,750,3750.51%
ARISTEIA CAPITAL, L.L.C. 25,280,000$18,960,0000.51%
SSI INVESTMENT MANAGEMENT LLC 8,217,000$6,121,6650.50%
ABSOLUTE INVESTMENT ADVISERS, LLC 4,604,000$3,430,5200.49%
View complete list of BRIDGEBIO PHARMA INC shareholders